Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ALGS

Aligos Therapeutics, Inc.

CIK 0001799448 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$6.77
↑ 0.04 (0.59%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Excluded: Options (no data)

Key stats

Market Cap
$288.46M
P/E Ratio
-3.19
EPS
-2.45
Dividend Yield
Not covered
52W Position
22%
Beta
1.29

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
9.07
P/S
61.31
EV/Revenue
54.94
ROE
-284.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$4.80$13.69

Latest Financials

2025-12-31 FY
Revenue
$2.19M
Net Income
-$24.19M
Total Assets
$88.53M
Free Cash Flow
–

Recent news